trending Market Intelligence /marketintelligence/en/news-insights/trending/tqywpfz8eopk8lhtr7z9ba2 content esgSubNav
In This List

Scythian Biosciences adds board member

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Scythian Biosciences adds board member

Scythian Biosciences Corp. appointed Andrew DeFrancesco to its board of directors, effective Sept. 4.

DeFrancesco is chairman of Cool Holdings Inc., a Nasdaq-listed investment company.

Toronto-based Scythian Biosciences develops cannabis-derived treatments for concussions and traumatic brain injuries.